Psoriatic Arthritis Research Study (Sparc II)
Do You Have Psoriatic Arthritis?
NOW ENROLLING FOR A LOCAL INVESTIGATIONAL STUDY
A member of our staff will be in contact with you shortly.
Fighting another flare up? Ready to try a different option?
We are searching for Springfield area applicants to participate in a clinical research study investigating a new medication to improve options for people diagnosed with Psoriatic Arthritis. If you believe you’d be a good fit for this study, contact Clinvest Research for more information.
WHAT SHOULD I EXPECT?
The purpose of this research study is to assess the study medication Tildrakizumab in Anti-TNF naive subjects with active psoriatic arthritis. The study had both a placebo-controlled phase and an open-label period. Completion of the study would involve coming into the office for 19 visits over approximately 64-week period. Your first appointment would last approximately 2-3 hours. If you qualify and choose to volunteer, we would provide study drug and all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, XRAYS and urine drug/pregnancy tests).
TO FIND OUT MORE
LEARN MORE ABOUT OUR STUDIES
Clinvest Research is a clinical investigation company based in southwest Missouri. We are constantly seeking participants for clinical trials in order to further options for sufferers of various conditions. Our doctors are a part of a select group of clinics in the U.S. that have been involved in over 200 Phase II-IV clinical research studies sponsored primarily by the pharmaceutical industry or studies created by doctors after patient observation.
Study visits are conducted via outpatient and do not require overnight stays. In fact, we pride ourselves in making your participation in the studies as easy and convenient as possible.
If you qualify and choose to join a study, you will be treated by our team of specialists and may receive study-related care at no cost. Call us at (417) 883-7889 to learn more.